0001093557-15-000226.txt : 20150717
0001093557-15-000226.hdr.sgml : 20150717
20150717190052
ACCESSION NUMBER: 0001093557-15-000226
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150715
FILED AS OF DATE: 20150717
DATE AS OF CHANGE: 20150717
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: DEXCOM INC
CENTRAL INDEX KEY: 0001093557
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330857544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8582000200
MAIL ADDRESS:
STREET 1: 6340 SEQUENCE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREGG TERRANCE H
CENTRAL INDEX KEY: 0001236388
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51222
FILM NUMBER: 15994764
MAIL ADDRESS:
STREET 1: AMYLIN PHARMACEUTICALS INC
STREET 2: 9360 TOWNE CENTRE DR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2015-07-15
0
0001093557
DEXCOM INC
DXCM
0001236388
GREGG TERRANCE H
6340 SEQUENCE DRIVE
SAN DIEGO
CA
92121
1
1
0
0
Executive Chairman
Common Stock
2015-07-15
4
S
0
15000.0
81.6405
D
417139
I
by Trust
Common Stock
2015-07-17
4
S
0
35750.0
83.67
D
381389
I
by Trust
Common Stock
430626
D
Common Stock
11461
I
by IRA
On December 12, 2014, Mr. Gregg adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Gregg. The shares set forth above were sold pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $81.32 to $82.34. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
Shares are held by the Gregg Family Trust U/A/D 12/23/1998, with respect to which the reporting person is a trustee.
The reporting person contributed Dexcom, Inc. Common Stock to an exchange fund, pursuant to an agreement dated March 5, 2015 to contribute shares of DexCom, Inc. Common Stock in exchange for shares of the exchange fund. The Dexcom, Inc. Common Stock was valued at $83.67 per share for the purposes of determining the number of shares of the exchange fund issuable to the reporting person with respect to the July 17, 2015 closing of the exchange fund.
By: Jess Roper For: Terrance H. Gregg
2015-07-17